Jaguar Health (JAGX) Proxy filing summary

Executive summary

• Proxy supplement updates Proposal 3 after the Series R Preferred Stock Dividend, with a six-fold 2014 Plan share-reserve adjustment intended to preserve the plan’s proportional share reserve.

• The special stockholder meeting is scheduled for November 6, 2026; the reserve adjustment takes effect immediately afterward.

Voting matters and shareholder proposals

• Proposal 3 asks stockholders to approve an amendment and restatement of the 2014 Plan, including a proposed reserve of 378,859 shares, equal to 14% of fully diluted shares as of September 30, 2026.

• Previously submitted proxies need not be resubmitted unless stockholders wish to change their vote on Proposal 3.

Board of directors and corporate governance

• The Compensation Committee approved the six-fold reserve adjustment under Section 4.3 of the 2014 Plan; the Board unanimously approved it on October 28, 2026.

• The adjustment takes effect immediately after the November 6, 2026 special meeting.